These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 35514416)

  • 1. Design and formulation of polymeric nanosponge tablets with enhanced solubility for combination therapy.
    Moin A; Roohi NKF; Rizvi SMD; Ashraf SA; Siddiqui AJ; Patel M; Ahmed SM; Gowda DV; Adnan M
    RSC Adv; 2020 Sep; 10(57):34869-34884. PubMed ID: 35514416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solubility and dissolution rate enhancement of ibuprofen by cyclodextrin based carbonate nanosponges.
    Shoaib QU; Latif S; Ijaz QA; Afzal H; Siddique MI; Hussain A; Arshad MS; Bukhari NI; Abbas N
    Pak J Pharm Sci; 2021 May; 34(3(Supplementary)):1045-1055. PubMed ID: 34602431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and Characterization of Carboxymethyl Chitosan Nanosponges with Cyclodextrin Blends for Drug Solubility Improvement.
    Rizvi SSB; Akhtar N; Minhas MU; Mahmood A; Khan KU
    Gels; 2022 Jan; 8(1):. PubMed ID: 35049590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation and Characterization of Curcumin-β-Cyclodextrin and Cyclodextrin-Based Nanosponge Inclusion Complexation.
    Mashaqbeh H; Obaidat R; Al-Shar'i N
    Polymers (Basel); 2021 Nov; 13(23):. PubMed ID: 34883577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimisation of a Greener-Approach for the Synthesis of Cyclodextrin-Based Nanosponges for the Solubility Enhancement of Domperidone, a BCS Class II Drug.
    Vij M; Dand N; Kumar L; Wadhwa P; Wani SUD; Mahdi WA; Alshehri S; Alam P; Shakeel F
    Pharmaceuticals (Basel); 2023 Apr; 16(4):. PubMed ID: 37111324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ester-Based Hydrophilic Cyclodextrin Nanosponges for Topical Ocular Drug Delivery.
    Hayiyana Z; Choonara YE; Makgotloe A; du Toit LC; Kumar P; Pillay V
    Curr Pharm Des; 2016; 22(46):6988-6997. PubMed ID: 27981908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formulation and evaluation of Piroxicam nanosponge for improved internal solubility and analgesic activity.
    Gaber DA; Radwan MA; Alzughaibi DA; Alail JA; Aljumah RS; Aloqla RM; Alkhalifah SA; Abdoun SA
    Drug Deliv; 2023 Dec; 30(1):2174208. PubMed ID: 36744372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of inclusion complexation of meloxicam with β-cyclodextrin- and β-cyclodextrin-based nanosponges on solubility, in vitro release and stability studies.
    Shende PK; Gaud RS; Bakal R; Patil D
    Colloids Surf B Biointerfaces; 2015 Dec; 136():105-10. PubMed ID: 26364091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Weak complexation of 5-fluorouracil with β-cyclodextrin, carbonate, and dianhydride crosslinked β-cyclodextrin:
    Mashaqbeh H; Obaidat R; Al-Shar'i NA; El-Elimat T; Alnabulsi S
    Res Pharm Sci; 2022 Aug; 17(4):334-349. PubMed ID: 36034082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of oral bioavailability of anti-HIV drug rilpivirine HCl through nanosponge formulation
    Zainuddin R; Zaheer Z; Sangshetti JN; Momin M
    Drug Dev Ind Pharm; 2017 Dec; 43(12):2076-2084. PubMed ID: 28845699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel cyclodextrin nanosponges for delivery of calcium in hyperphosphatemia.
    Shende P; Deshmukh K; Trotta F; Caldera F
    Int J Pharm; 2013 Nov; 456(1):95-100. PubMed ID: 23954237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formulation Development, In Vitro and In Vivo Evaluation of Topical Hydrogel Formulation of Econazole Nitrate-Loaded β-Cyclodextrin Nanosponges.
    Srivastava S; Mahor A; Singh G; Bansal K; Singh PP; Gupta R; Dutt R; Alanazi AM; Khan AA; Kesharwani P
    J Pharm Sci; 2021 Nov; 110(11):3702-3714. PubMed ID: 34293406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclodextrin-based nanosponge for improvement of solubility and oral bioavailability of Ellagic acid.
    Mady FM; Ibrahim SR
    Pak J Pharm Sci; 2018 Sep; 31(5(Supplementary)):2069-2076. PubMed ID: 30393214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanosponge-based pediatric-controlled release dry suspension of Gabapentin for reconstitution.
    Rao MR; Bhingole RC
    Drug Dev Ind Pharm; 2015; 41(12):2029-36. PubMed ID: 26006328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bi-polymeric Spongy Matrices Through Cross-linking Polymerization: Synthesized and Evaluated for Solubility Enhancement of Acyclovir.
    Asghar S; Akhtar N; Minhas MU; Khan KU
    AAPS PharmSciTech; 2021 Jun; 22(5):181. PubMed ID: 34129154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formulation Optimization and Biopharmaceutical Evaluation of Imatinib Mesylate Loaded β-cyclodextrin Nanosponges.
    Kamble M; Zaheer Z; Mokale S; Zainuddin R
    Pharm Nanotechnol; 2019; 7(5):343-361. PubMed ID: 31549599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of solubility enhancement, antioxidant activity, and cytotoxicity studies of kynurenic acid loaded cyclodextrin nanosponge.
    Dhakar NK; Caldera F; Bessone F; Cecone C; Pedrazzo AR; Cavalli R; Dianzani C; Trotta F
    Carbohydr Polym; 2019 Nov; 224():115168. PubMed ID: 31472867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclodextrin-based nanosponges for delivery of resveratrol: in vitro characterisation, stability, cytotoxicity and permeation study.
    Ansari KA; Vavia PR; Trotta F; Cavalli R
    AAPS PharmSciTech; 2011 Mar; 12(1):279-86. PubMed ID: 21240574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of Cyclodextrin-Based Nanosponges for Solubility and Bioavailability Enhancement of Rilpivirine.
    Rao MRP; Chaudhari J; Trotta F; Caldera F
    AAPS PharmSciTech; 2018 Jul; 19(5):2358-2369. PubMed ID: 29869305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paclitaxel loaded nanosponges: in-vitro characterization and cytotoxicity study on MCF-7 cell line culture.
    Ansari KA; Torne SJ; Vavia PR; Trotta F; Cavalli R
    Curr Drug Deliv; 2011 Mar; 8(2):194-202. PubMed ID: 21235471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.